Literature DB >> 8494196

Mechanism of airway inflammation in asthma.

W W Busse1, W F Calhoun, J D Sedgwick.   

Abstract

Airway inflammation has emerged as an important contributor to mechanisms of asthma. Furthermore, the presence of airway inflammation is present even in the absence of severe symptoms. To study the mechanisms by which bronchial inflammation can occur in asthma, a number of models have been developed including the airway response to antigen in allergic subjects. The pattern that has emerged from such studies indicates prompt pulmonary mast-cell activation and the apparent initiation of an inflammatory response. This inflammatory response develops over hours and is important in the later and more persistent development of bronchial obstruction. The eosinophil is an important cell in this process as are proinflammatory cytokines generated from activated lung mononuclear cells. The consequence of this multiple cell, multiple proinflammatory product interaction is the establishment of a self-perpetuating, redundant process by which asthma severity increases.

Entities:  

Mesh:

Year:  1993        PMID: 8494196     DOI: 10.1164/ajrccm/147.6_Pt_2.S20

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  23 in total

1.  Hesperidin suppresses ovalbumin-induced airway inflammation in a mouse allergic asthma model.

Authors:  Dajun Wei; Xinxin Ci; Xiao Chu; Miaomiao Wei; Shucheng Hua; Xuming Deng
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

2.  Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation.

Authors:  J R Brown; J Kleimberg; M Marini; G Sun; A Bellini; S Mattoli
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

3.  Contractile responses to adenosine, R-PIA and ovalbumen in passively sensitized guinea-pig isolated airways.

Authors:  Timothy J Martin; Kenneth J Broadley
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

4.  Complement components (C3, C4) in childhood asthma.

Authors:  F I E Najam; A S M Giasuddin; A H Shembesh
Journal:  Indian J Pediatr       Date:  2005-09       Impact factor: 1.967

5.  Applicability of an ultrasonic nebulization system for the airways delivery of beclomethasone dipropionate in a murine model of asthma.

Authors:  Boska Hrvacić; Berislav Bosnjak; Marijan Tudja; Milan Mesić; Mladen Merćep
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

6.  Regulator of calcineurin 1 (Rcan1) is required for the development of pulmonary eosinophilia in allergic inflammation in mice.

Authors:  Yong Jun Yang; Adam J Macneil; Robert Junkins; Svetlana O Carrigan; Jin-Tian Tang; Nicholas Forward; David Hoskin; Jason N Berman; Tong-Jun Lin
Journal:  Am J Pathol       Date:  2011-07-08       Impact factor: 4.307

7.  Pulmonary pharmacology of WAY-126299A: a dual-acting 5-lipoxygenase inhibitor and leukotriene D4 antagonist.

Authors:  R E Howell; L P Jenkins; D A Hartman; W B Gray; D Kubrak; R P Carlson; A F Kreft; D Grimes
Journal:  Inflamm Res       Date:  1995-08       Impact factor: 4.575

8.  Administration of interleukin-12 exerts a therapeutic instead of a long-term preventive effect on mite Der p I allergen-induced animal model of airway inflammation.

Authors:  Y Lee; C Fu; B Chiang
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

9.  Allergies and Asthma in Relation to Cancer Risk.

Authors:  Elizabeth D Kantor; Meier Hsu; Mengmeng Du; Lisa B Signorello
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-06-05       Impact factor: 4.254

Review 10.  Nasobronchial interaction.

Authors:  Cemal Cingi; Nuray Bayar Muluk; Bengu Cobanoglu; Tolgahan Çatli; Oğuzhan Dikici
Journal:  World J Clin Cases       Date:  2015-06-16       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.